Browsing Category

45032 posts
Wahed, an Islamic robo-advisor, appoints Shahril Hamdan to its Board of Directors

Wahed, an Islamic robo-advisor, appoints Shahril Hamdan to its Board of Directors

KUALA LUMPUR, Malaysia, March 6, 2025 /PRNewswire/ — Wahed, a global Shariah-compliant fintech…
Movement Labs Announces "GMove: Move Asia's Future" APAC Tour Following Mainnet Launch

Movement Labs Announces "GMove: Move Asia's Future" APAC Tour Following Mainnet Launch

SAN FRANCISCO, March 6, 2025 /PRNewswire/ — Movement Labs, a Web3 company…
HKA WELCOMES ADAM SMITH AS A PRINCIPAL IN THE ADVISORY TEAM IN AUSTRALIA

HKA WELCOMES ADAM SMITH AS A PRINCIPAL IN THE ADVISORY TEAM IN AUSTRALIA

SYDNEY, March 6, 2025 /PRNewswire/ — HKA, a leading infrastructure project, strategy,…
WESTIN WELLNESS WEEKEND : WELLNESS BEFORE THE RUN

WESTIN WELLNESS WEEKEND : WELLNESS BEFORE THE RUN

Prepare, recover, and recharge with expert-led wellness experiences tailored for runners SINGAPORE,…
Getac's Next Generation B360 and B360 Pro Combine Powerful AI-Ready Technology with Fully Rugged Reliability for Exceptional Versatility and Performance

Getac's Next Generation B360 and B360 Pro Combine Powerful AI-Ready Technology with Fully Rugged Reliability for Exceptional Versatility and Performance

Both laptops also offer an extensive range of industry-specific configurations and customisation flexibility*,…
Wahed, an Islamic robo-advisor, appoints Shahril Hamdan to its Board of Directors

Wahed, an Islamic robo-advisor, appoints Shahril Hamdan to its Board of Directors

KUALA LUMPUR, Malaysia, March 6, 2025 /PRNewswire/ — Wahed, a global Shariah-compliant fintech…
SOL ARENA USHERS IN A NEW ERA OF CASUAL GAMING AND CRYPTO WAGERING ON SOLANA, WITH $CHILL TOKEN LAUNCHING SOON

SOL ARENA USHERS IN A NEW ERA OF CASUAL GAMING AND CRYPTO WAGERING ON SOLANA, WITH $CHILL TOKEN LAUNCHING SOON

SOL Arena, the Web3 multiplayer battle game developed by Chillchat, will launch its…

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

HONG KONG, March 6, 2025 /PRNewswire/ — Akeso, Inc. (9926. HK) ("Akeso"…